cIAP2 antibody [C1C3]
GTX113128
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetBIRC3
Overview
- SupplierGeneTex
 - Product NamecIAP2 antibody [C1C3]
 - Delivery Days Customer9
 - Application Supplier NoteWB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
 - ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
 - CertificationResearch Use Only
 - ClonalityPolyclonal
 - Concentration0.67 mg/ml
 - ConjugateUnconjugated
 - Gene ID330
 - Target nameBIRC3
 - Target descriptionbaculoviral IAP repeat containing 3
 - Target synonymsAIP1, API2, CIAP2, HAIP1, HIAP1, IAP-1, MALT2, MIHC, RNF49, c-IAP2, baculoviral IAP repeat-containing protein 3, IAP homolog C, RING finger protein 49, RING-type E3 ubiquitin transferase BIRC3, TNFR2-TRAF signaling complex protein, TNFR2-TRAF-signaling complex protein 1, apoptosis inhibitor 2, cellular inhibitor of apoptosis 2, inhibitor of apoptosis protein 1, mammalian IAP homolog C
 - HostRabbit
 - IsotypeIgG
 - Protein IDQ13489
 - Protein NameBaculoviral IAP repeat-containing protein 3
 - Scientific DescriptionThe protein encoded by this gene is a member of a family of proteins that inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. The encoded protein inhibits apoptosis induced by serum deprivation but does not affect apoptosis resulting from exposure to menadione, a potent inducer of free radicals. The amino acid sequence predicts three baculovirus IAP repeat domains and a ring finger domain. Transcript variants encoding the same isoform have been identified. [provided by RefSeq]
 - Storage Instruction-20°C or -80°C,2°C to 8°C
 - UNSPSC12352203
 
References
- SP110b Controls Host Immunity and Susceptibility to Tuberculosis. Leu JS et al., 2017 Feb 1, Am J Respir Crit Care MedRead more
 - Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro. Huang YT et al., 2016 Jan, Int J Mol MedRead more
 





